Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04573946 · ClinicalTrials.gov registry record · NA

VITamin D and OmegA-3 TriaL: Interrelationship of Vitamin D and Vitamin K on Bone (VITAL)

A NA study of Bone Density and Fractures, sponsored by Brigham and Women's Hospital.

Active
Registry status
NA
Development phase
25,871
Enrollment target
1
Study location

NCT04573946 is a NA study of Bone Density and Fractures that is active but no longer recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 25,871 participants, above the 71-participant average among 7 other Bone Density trials with a reported enrollment target (36338% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04573946, a NA study of Bone Density and Fractures, is active but no longer recruiting, sponsored by Brigham and Women's Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
25,871 participants
Enrollment target
1
Study location

Study Summary

Vitamin D supplements are widely promoted for bone health. Both vitamin D and vitamin K are important for deposition of calcium in bone, but little is known about the relationship of vitamin K status and bone health.

Interventions

  • DIETARY_SUPPLEMENT Vitamin D3
  • DIETARY_SUPPLEMENT Vitamin D3 placebo
  • DIETARY_SUPPLEMENT Fish oil placebo
  • DRUG Omega-3 fatty acids (fish oil)

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 25,871 participants
Start Date 2019-07-01
Est. Completion 2026-12-31
Phase NA

Sponsor

Brigham and Women's Hospital

937 total trials

What the Registry Record Tells You About NCT04573946

The ClinicalTrials.gov registry entry for NCT04573946 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 25,871 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 71-participant average among 7 other Bone Density trials with a reported enrollment target (36338% higher). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Bone Density appearing as the primary indexed condition, and to 4 interventions - of which Vitamin D3 is the first listed.

NCT04573946 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04573946 about?

NCT04573946 is a clinical study titled "VITamin D and OmegA-3 TriaL: Interrelationship of Vitamin D and Vitamin K on Bone (VITAL)". Vitamin D supplements are widely promoted for bone health. Both vitamin D and vitamin K are important for deposition of calcium in bone, but little is known about the relationship of vitamin K status and bone health.

What is the current status of trial NCT04573946?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 25,871 participants. The study started on 2019-07-01. Estimated completion is 2026-12-31.

What conditions does trial NCT04573946 study?

This clinical trial studies the following conditions: Bone Density, Fractures, Bone Health.

What interventions are being tested in trial NCT04573946?

The interventions under investigation include: Vitamin D3 (DIETARY_SUPPLEMENT), Vitamin D3 placebo (DIETARY_SUPPLEMENT), Fish oil placebo (DIETARY_SUPPLEMENT), Omega-3 fatty acids (fish oil) (DRUG).

Who is sponsoring clinical trial NCT04573946?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04573946 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bone Density

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.